Mycoplasma infections vaccine - M Bio Technology
Latest Information Update: 28 Sep 2022
At a glance
- Originator M Bio Technology
- Class Bacterial vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Mycoplasma infections
Most Recent Events
- 28 Sep 2022 No recent reports of development identified for research development in Mycoplasma-infections in China
- 28 Aug 2018 Mycoplasma infections vaccine - M Bio Technology is available for licensing as of 28 Aug 2018. http://www.mbiotech.org/English/company4.html
- 28 Aug 2018 Early research in Mycoplasma infections in China (unspecified route) (M Bio Technology website, August 2018)